Results 41 to 50 of about 2,300 (90)

The complex price setting and reimbursement of non-industrial advanced therapy medicinal products. [PDF]

Health Econ Rev
Špacírová Z, Rejon-Parrilla JC, Espín J.   +2 more
europepmc   +1 more source

Designs of the clinical trials aiming at evaluating cell and gene therapy products: A critical appraisal from a literature review. [PDF]

Mol Ther Adv
Biard L, Lévy V, Chevret S, JOIN4ATMP consortium.   +3 more
europepmc   +1 more source

Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice. [PDF]

Front Pharmacol
Delemarre L, Huys I, Van Dyck W, Simoens S.   +3 more
europepmc   +1 more source

Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. [PDF]

Regen Ther
Shi J, Hu H, Ung COL.
europepmc   +1 more source

Magnetically Driven Biofabrication for Tissue Engineering: From Nanoparticle Design to Mag-ATMP Translation. [PDF]

Adv Healthc Mater
Ioannidis K, Lefas D, Guilliams M, Van Grootenbril J, Decoene I, Sakellariou D, Smeets B, Mourdikoudis S, Papantoniou I.   +8 more
europepmc   +1 more source

The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects. [PDF]

Signal Transduct Target Ther
Lu J, Cui J, Dong J, Yan L, Wang X, Zhou D, Lu S, Wei W.   +7 more
europepmc   +1 more source

Unproven stem cell-based interventions marketed as treatments in Panama: An urgent call for enforcement actions. [PDF]

Stem Cell Reports
Solis MA, Quintana M, Candanedo P JE, Trujillo-Sagel RI, Chambonnet L, Lasso S, Members of the National Research Bioethics Committee.   +6 more
europepmc   +1 more source

Advances in cell therapy for solid tumours: European perspective and future directions. [PDF]

Lancet Reg Health Eur
Moreno V, Thistlethwaite F, Yarza R, Tak WS, Lim KHJ, Haanen JBAG.   +5 more
europepmc   +1 more source

Hospital exemption use of virus-specific T-lymphocytes in children: early experience within the Allovista clinical trial framework. [PDF]

Front Immunol
Ussowicz M, Ślęzak A, Myszka-Kozłowska M, Gajek K, Jopek K, Bukowska M, Bukowska A, Jureczek J, Jarmużek W, Litwin M, Deręgowski M, Derwich K, Czyż A, Bogacz A.   +13 more
europepmc   +1 more source

Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link. [PDF]

Bone Marrow Transplant
Chartral U, Galaine J, Giverne C, Auxenfans C, Reppel L, Marton C, Thiant S, Clémenceau B, Derenne S, Sabatier F, Veran J, Moisan A, Rouard H, Tertrais K, Dachy G, Demerle C, Calmels B, Chabannon C, Forcade E, Viel S, Bensoussan D, de Vos J, Galy A, De Oliveira C, Boucher H, Magrin E, Fabreguettes JR, Cavazzana M, Larghero J, Deschamps M, Martinet J, Boyer O, Ferrand C, Yakoub-Agha I, Diana JS.   +34 more
europepmc   +1 more source